Sudafed and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sudafed (pseudoephedrine hydrochloride) and Keppra (levetiracetam). Common drug interactions include tachypnoea among females and priapism among males.

The phase IV clinical study analyzes what interactions people have when they take Sudafed and Keppra. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Sudafed?

Sudafed has active ingredients of pseudoephedrine hydrochloride. It is often used in nasal congestion. eHealthMe is studying from 12,944 Sudafed users. Check the latest studies of Sudafed.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.



On Jul, 12, 2026

60 people who take Sudafed and Keppra together, and have interactions are studied.

Sudafed and Keppra drug interactions.

What are the common drug interactions of Sudafed and Keppra, by gender? *:

female:

  1. Tachypnoea (a condition of rapid breathing over 20 per minute)
  2. Urinary tract infection
  3. Vasculitis (inflammation of a blood vessel or blood vessels)
  4. Decreased appetite
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  8. Hoarseness (changing voice)
  9. Induced labour (prematurely stimulating childbirth in a woman)
  10. Lethargy (tiredness)

male:

  1. Priapism (prolonged and painful erection that can last from several hours up to a few days)
  2. Pyrexia (fever)
  3. Stress
  4. Weight increased
  5. Cold sweat
  6. Constipation
  7. Death
  8. Device failure
  9. Diarrhoea
  10. Drug hypersensitivity

What are the common drug interactions of Sudafed and Keppra, by age (0-1 to 60+)? *:

0-1:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Pyrexia (fever)

2-9:

n/a

10-19:

n/a

20-29:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Drug exposure during pregnancy
  4. Electrocardiogram qt prolonged

30-39:

  1. Constipation
  2. Cough
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  6. Dry mouth
  7. Dyspnoea (difficult or laboured respiration)
  8. Epistaxis (bleed from the nose)
  9. Erythema multiforme (a type of hypersensitivity reaction)
  10. Escherichia sepsis (bacterial infection by escherichia coli)

40-49:

  1. Epistaxis (bleed from the nose)
  2. Infection
  3. Pre-eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman)
  4. Pyrexia (fever)
  5. Induced labour (prematurely stimulating childbirth in a woman)
  6. Asthenia (weakness)
  7. Fatigue (feeling of tiredness)
  8. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  9. Pain
  10. Cerebral infarction (less blood supply to brain resulting tissue damage)

50-59:

  1. Fatigue (feeling of tiredness)
  2. Neuropathy peripheral (surface nerve damage)
  3. Pain
  4. Anxiety
  5. Application site pruritus (application site severe itching of the skin)
  6. Blood pressure increased
  7. Conjunctival scar (conjunctival scarring)
  8. Death
  9. Diarrhoea
  10. Drug ineffective

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Bradycardia (abnormally slow heart action)
  3. Cataract (clouding of the lens inside the eye)
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Road traffic accident
  6. Vomiting
  7. Anticonvulsant drug level below therapeutic
  8. Chronic kidney disease
  9. Constipation
  10. Coronary arterial stent insertion

What are the existing conditions these people have? *

  1. Sinusitis (inflammation of sinus): 9 people, 15.00%
  2. Asthma: 9 people, 15.00%
  3. Sinus Congestion (blockage of sinus): 8 people, 13.33%
  4. Insomnia (sleeplessness): 8 people, 13.33%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 8 people, 13.33%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 11.67%
  7. Depression: 7 people, 11.67%
  8. Post-Traumatic Stress Disorder: 6 people, 10.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 8.33%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Sudafed and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sudafed and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sudafed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sudafed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pseudoephedrine hydrochloride and levetiracetam (the active ingredients of Sudafed and Keppra, respectively), and Sudafed and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: